Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial - Concepedia

Concepedia

Publication | Closed Access

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

477

Citations

29

References

2014

Year

Kathleen Dungan, Santiago Tofé, Thomas Först, José Gerardo González‐González, Charles Atisso, Whitney Sealls, Jessie L. Fahrbach

Diabetes ManagementOnce-weekly DulaglutideDiabetesType 2Clinical TrialsPharmacotherapyNon-inferiority TrialDiabetes MellitusMedicine

References

	Year	Citations

Page 1